Intelligent Blood Sequestration System with Integrated Technologies
Legal Citation
Summary of the Inventive Concept
The inventive concept integrates a blood sequestration device with advanced technologies such as AI, IoT, blockchain, and nanomaterials to create a more powerful system for blood culture testing, enabling enhanced infection risk prediction, secure data storage, and real-time monitoring of blood sample quality.
Background and Problem Solved
The original patent addressed the need for a device to inhibit potentially contaminated blood from inclusion in a blood culture test sample. However, the existing device lacked the capabilities to analyze blood sample data, transmit results to healthcare providers, and ensure secure data storage. The new inventive concept solves these limitations by incorporating synergistic combinations of technologies to create a more comprehensive and efficient system.
Detailed Description of the Inventive Concept
The inventive concept comprises a blood sequestration device integrated with a machine learning module, a communication module, an IoT-based healthcare network, a blockchain-based data storage system, an AI-powered analysis module, and a reporting module. The machine learning module analyzes blood sample data to predict infection risks, which are transmitted to healthcare providers through the communication module. The IoT-based healthcare network enables seamless data transmission and reception. The blockchain-based data storage system ensures secure and tamper-proof storage of blood sample data and associated metadata. The AI-powered analysis module interprets test results, and the reporting module generates a comprehensive report for healthcare providers. Additionally, the device features a nanomaterial-based coating for enhanced biocompatibility and reduced risk of infection, which is integrated with a sensor module for real-time monitoring of blood sample quality.
Novelty and Inventive Step
The new claims introduce novel and non-obvious combinations of technologies, including the integration of AI, IoT, blockchain, and nanomaterials with a blood sequestration device. These synergistic combinations enable enhanced functionality, security, and efficiency in blood culture testing, distinguishing the inventive concept from the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include integrating the blood sequestration device with other advanced technologies, such as robotics or 3D printing, to further enhance its capabilities. Variations could include adapting the device for use in different medical settings or for testing different types of biological samples.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in the fields of infectious disease diagnosis and treatment. The system's ability to predict infection risks, ensure secure data storage, and provide real-time monitoring of blood sample quality could revolutionize the way blood culture testing is performed, making it a valuable solution for hospitals, clinics, and research institutions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically blood collection and diagnostic technologies, with expertise in mechanical design, biomedical instrumentation, and medical device integration
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 3-5 years professional experience, familiar with medical device design, diagnostic technologies, and emerging healthcare technology integration
Obviousness Rationale
A PHOSITA would recognize that integrating advanced digital technologies with existing medical diagnostic devices represents a predictable evolution of blood sequestration systems. The fundamental mechanical principles of the source patent provide a clear technological foundation for adding intelligent monitoring and data management capabilities. The proposed variations represent logical extensions of existing medical device design principles, utilizing well-established technological integration strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,320 |
|---|---|
| Title | Blood sequestration device and method |
| Assignee(s) | Smiths Medical ASD, Inc. |